Bavencio Side Effects

Generic name: avelumab

Medically reviewed by Philip Thornton, DipPharm. Last updated on Oct 17, 2024.

Note: This document provides detailed information about Bavencio Side Effects associated with avelumab. Some dosage forms listed on this page may not apply specifically to the brand name Bavencio.

Applies to avelumab: intravenous solution.

Serious side effects of Bavencio

Along with its needed effects, avelumab (the active ingredient contained in Bavencio) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking avelumab:

More common side effects

• back pain
• bloating or swelling of the face, arms, hands, lower legs, or feet
• chest tightness
• blurred vision
• chills
• clay-colored stools
• confusion
• constipation
• cough
• dark urine
• decreased appetite
• depressed mood
• dizziness, fainting, or lightheadedness when getting up suddenly from a lying or sitting position
• dry skin and hair
• feeling warm or cold
• fever
• hair loss
• headache
• hives or welts, itching, or skin rash
• hoarseness
• irritation
• joint pain, stiffness, or swelling
• muscle cramps and stiffness
• nausea
• nervousness
• pounding in the ears
• rapid weight gain
• redness of the face, neck, arms, and occasionally, upper chest
• redness, swelling, or pain of the skin
• scaling of the skin on the hands and feet
• slow or fast heartbeat
• stomach pain
• sweating
• swelling of the eyelids, face, lips, hands, or feet
• tingling of the hands or feet
• trouble breathing or swallowing
• ulceration of the skin
• unusual tiredness or weakness
• unusual weight gain or loss
• vomiting
• yellow eyes or skin

Less common side effects

• bloody urine
• chest pain
• decreased frequency or amount of urine
• general feeling of discomfort or illness
• increased thirst
• lower back or side pain
• pain in the chest, groin, or legs, especially the calves
• severe, sudden headache
• slurred speech
• sneezing
• sore throat
• stomach cramps
• sudden loss of coordination
• sudden, severe weakness or numbness in the arm or leg
• swelling of the face, fingers, lower legs
• thickening of bronchial secretions
• vision changes
• watery or bloody diarrhea

Rare side effects

• blistering, peeling, or loosening of the skin
• chest discomfort
• cloudy urine
• darkening of the skin
• difficulty in speaking
• double vision
• drowsiness
• dry mouth
• fruit-like breath odor
• inability to move the arms, legs, or facial muscles
• inability to speak
• increased hunger
• increased urination
• indigestion
• loss of appetite
• loss of consciousness
• muscle pain
• pains in the stomach, side, or abdomen, possibly radiating to the back
• red skin lesions, often with a purple center
• red, irritated eyes
• sensitivity to heat
• slow speech
• sores, ulcers, or white spots in the mouth or on the lips
• swollen glands
• trouble sleeping
• unexplained weight loss
• upper right abdominal or stomach pain

Other side effects of Bavencio

Some side effects of avelumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

• bone pain
• cracked lips
• decreased weight
• difficulty in moving
• voice changes

For healthcare professionals

Applies to avelumab: intravenous solution.

Cardiovascular adverse events

• Very common (10% or more): Hypotension (25%), hypertension (13%)
• Uncommon (0.1% to 1%): Myocarditis^[Ref]

Dermatologic

• Very common (10% or more): Urticaria (25%), rash (e.g., maculopapular, erythema, dermatitis bullous) (22%), pruritus (10%)
• Uncommon (0.1% to 1%): Psoriasis, arthritis, exfoliative dermatitis, pemphigoid, Stevens Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), histiocytic necrotizing lymphadenitis, vasculitis, hypophysitis^[Ref]

Endocrine

• Common (1% to 10%): Immune-mediated thyroid disorders (hypothyroidism/hyperthyroidism)
• Uncommon (0.1% to 1%): Adrenal insufficiency, hypopituitarism, hypophysitis^[Ref]

Gastrointestinal

• Very common (10% or more): Abdominal pain (25%), diarrhea (23%), nausea (22%), constipation (17%)
• Common (1% to 10%): Immune-mediated colitis
• Uncommon (0.1% to 1%): Pancreatitis^[Ref]

Hematologic

• Very common (10% or more): Lymphopenia (49%), anemia (35%), thrombocytopenia (27%)
• Common (1% to 10%): Neutropenia
• Rare (0.01% to 0.1%): Hemolytic anemia^[Ref]

Hepatic

• Very common (10% or more): Increased aspartate aminotransferase (AST) (34%), increased alanine aminotransferase (ALT) (20%)
• Common (1% to 10%): Increased bilirubin
• Uncommon (0.1% to 1%): Immune-mediated hepatitis^[Ref]

Immunologic

• Common (1% to 10%): Immunogenicity^[Ref]

Local

• Very common (10% or more): Anorexia (20%), weight loss (15%), increased lipase (14%)
• Common (1% to 10%): Increased amylase^[Ref]

Metabolic

• Very common (10% or more): Anorexia (20%), weight loss (15%), increased lipase (14%)
• Common (1% to 10%): Increased amylase^[Ref]

Musculoskeletal

• Very common (10% or more): Musculoskeletal pain (32%), back pain (25%), arthralgia (16%)

Common (1% to 10%):

• Uncommon (0.1% to 1%): Myositis, rhabdomyolysis, myasthenia gravis^[Ref]

Nervous system

• Very common (10% or more): Dizziness (14%), headache (10%)
• Uncommon (0.1% to 1%): Guillain-Barre syndrome, demyelination, encephalitis^[Ref]

Respiratory

• Very common (10% or more): Couth (18%), dyspnea (11%)
• Common (1% to 10%): Immune-mediated pneumonitis, wheezing^[Ref]

Renal

• Rare (less than 0.1%): Immune-mediated nephritis^[Ref]

Other

• Very common (10% or more): Fatigue (50%), pyrexia (25%), chills (25%), flushing (25%), peripheral edema (20%)^[Ref]

Ocular

• Uncommon (0.1% to 1%): Uveitis, iritis^[Ref]

Frequently asked questions

• Who makes Bavencio and where is it made?
• What type of drug is Bavencio?

Further information

Bavencio side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer